Surgical treatment of intramedullary spinal cord metastases of systemic cancer: Functional outcome and prognosis

T. Gasser, I.E. Sandalcioglu, B. El Hamalawi, O. Müller, J.A.P. Van De Nes & U. Sure
Objective: Intramedullary spinal cord metastases (ISCM) of systemic cancer are rare. To date, patients with ISCM tend to benefit only to a limited extent from surgery and adjuvant therapy. Subject of this investigation is to assess predictive factors for the surgical outcome and survival and to evaluate[for full text, please go to the a.m. URL]